TREATMENT ADHERENCE AMONG CHILDREN AND ADOLESCENTS IN A CYSTIC FIBROSIS REFERENCE CENTER.

Publisher: Sociedade De Pediatria De Sao Paulo Country of Publication: Brazil NLM ID: 9109353 Publication Model: eCollection Cited Medium: Internet ISSN: 1984-0462 (Electronic) Linking ISSN: 01030582 NLM ISO Abbreviation: Rev Paul Pediatr Subsets: MEDLINE

Publication: 2017- : Sao Paulo : Sociedade De Pediatria De Sao Paulo
Original Publication: Sao Paulo : Sociedade De Pediatria De Sao Paulo

Cystic Fibrosis/*therapy ; Treatment Adherence and Compliance/*statistics & numerical data; Adolescent ; Age Factors ; Child ; Child, Preschool ; Combined Modality Therapy ; Cross-Sectional Studies ; Cystic Fibrosis/psychology ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Self Report ; Treatment Adherence and Compliance/psychology ; Young Adult

Objective: To evaluate the level of self-referenced treatment adherence (TA) and its association with clinical and sociodemographic variables in patients with cystic fibrosis assisted at a reference center, as well as compare the level of self-referenced TA with that presumed by the multidisciplinary team.
Methods: This is a cross-sectional study that included children and adolescents aged between 0-20 years with cystic fibrosis. Adolescents older than 14 years or their guardians, when younger than 14 years old, were interviewed using a standardized questionnaire. Professionals from the multidisciplinary clinic filled out another form with their impressions of the patients' TA. Clinical and laboratory data were obtained in the medical records. The TA was considered satisfactory if the total adherence index (TAI) was equal or higher than 80%.
Results: 53 patients were included with a median age of 112 months. The mean TAI was 83.2%. The mean TAIs for dornase alfa, pancreatic enzymes, continued use of inhaled tobramycin, vitamins supplements, nutritional supplements and dietary orientation was respectively: 86.1; 96.6; 78.6; 88.1; 51.8 and 78%. Children younger than 14 years presented better TA (p=0.021). The correlation between the self-referenced TA and the one presumed by the multidisciplinary team ranged from 0,117 to 0.402, being higher for Psychology and Nutrition professionals.
Conclusions: The TAI was high particularly among children younger than 14 years. There was a positive correlation between the self-referenced TA and the one presumed by the Psychology (p=0.032) and the nutrition (p=0.012) professionals.

J R Soc Med. 2000;93 Suppl 38:2-8. (PMID: 10911812)
Respir Care. 2014 Nov;59(11):1731-46. (PMID: 25233386)
Chest. 2014 Jul;146(1):142-151. (PMID: 24480974)
J Cyst Fibros. 2009 Mar;8(2):91-6. (PMID: 18952504)
Respir Care. 2013 Feb;58(2):279-85. (PMID: 22782067)
Health Qual Life Outcomes. 2005 Mar 24;3:19. (PMID: 15790407)
J Clin Pharm Ther. 2001 Oct;26(5):331-42. (PMID: 11679023)
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1433-1442. (PMID: 29327948)
J Bras Pneumol. 2007 Nov-Dec;33(6):663-70. (PMID: 18200366)
AMA J Dis Child. 1958 Jul;96(1):6-15. (PMID: 13544726)
Thorax. 1996 Jan;51(1):29-33. (PMID: 8658364)
Pediatr Pulmonol. 2015 Feb;50(2):127-36. (PMID: 24616259)
J Cyst Fibros. 2008 Sep;7(5):359-67. (PMID: 18304896)
Pediatr Pulmonol. 2015 Dec;50(12):1224-9. (PMID: 26346919)
J Bras Pneumol. 2016 Jan-Feb;42(1):29-34. (PMID: 26982038)
J Cyst Fibros. 2006 Aug;5(3):177-85. (PMID: 16679071)
Expert Rev Respir Med. 2017 Feb;11(2):129-145. (PMID: 28107795)
J Cyst Fibros. 2010 Dec;9(6):425-32. (PMID: 20846910)
J Cyst Fibros. 2013 Sep;12(5):440-4. (PMID: 23369661)
Int J Clin Pharm. 2016 Apr;38(2):296-302. (PMID: 26715548)
Pediatr Pulmonol. 2010 May;45(5):450-8. (PMID: 20425852)
Pediatr Pulmonol. 2011 Nov;46(11):1085-92. (PMID: 21626713)
Anthropol Med. 2017 Apr;24(1):65-80. (PMID: 28292207)
Curr Opin Pulm Med. 2016 Mar;22(2):187-91. (PMID: 26814144)
J Cyst Fibros. 2015 Jan;14(1):142-8. (PMID: 25459564)

Date Created: 20200611 Date Completed: 20210325 Latest Revision: 20210325

20221213

PMC7274532

10.1590/1984-0462/2020/38/2018338

32520296